| Basics |
Laboratory Corporation of America Holdings
Laboratory Corp of America Holdings is a healthcare diagnostics company. It is engaged in providing comprehensive clinical laboratory and end-to-end drug development services. It operates in two segments: LabCorp Diagnostics and Covance Drug Development.
|
| IPO Date: |
May 9, 1995 |
| Sector: |
Healthcare |
| Industry: |
Health Care Providers and Services |
| Market Cap: |
$23.16B |
| Activated in VL: |
True |
| Average Daily Range |
| Avg Daily Range: |
$1.19 | 0.89%
|
| Avg Daily Range (30 D): |
$1.86 | 0.69%
|
| Avg Daily Range (90 D): |
$2.23 | 0.88%
|
| Institutional Daily Volume |
| Avg Daily Volume: |
.8M |
| Avg Daily Volume (30 D): |
.43M |
| Avg Daily Volume (90 D): |
.54M |
| Trade Size |
| Avg Trade Size (Sh.): |
93 |
| Avg Trade Size (Sh.) (30 D): |
31 |
| Avg Trade Size (Sh.) (90 D): |
33 |
| Institutional Trades |
| Total Inst.Trades: |
19,202 |
| Avg Inst. Trade: |
$5.07M |
| Avg Inst. Trade (30 D): |
$16.81M |
| Avg Inst. Trade (90 D): |
$17.13M |
| Avg Inst. Trade Volume: |
.04M |
| Avg Inst. Trades (Per Day): |
3 |
| Market Closing Trades |
| Avg Closing Trade: |
$12.29M |
| Avg Closing Trade (30 D): |
$25.65M |
| Avg Closing Trade (90 D): |
$29.62M |
| Avg Closing Volume: |
70.65K |
|
|
| Financials |
| |
TTM |
Q2 2025 |
Q1 2025 |
|
Basic EPS
|
$9.14
|
$2.85
|
$2.54
|
|
Diluted EPS
|
$9.07
|
$2.84
|
$2.52
|
|
Revenue
|
$ 13.48B
|
$ 3.53B
|
$ 3.35B
|
|
Gross Profit
|
$ 3.79B
|
$ 1.05B
|
$ 948M
|
|
Net Income / Loss
|
$ 764.5M
|
$ 238.3M
|
$ 213M
|
|
Operating Income / Loss
|
$ 1.19B
|
$ 394.5M
|
$ 326M
|
|
Cost of Revenue
|
$ 9.69B
|
$ 2.48B
|
$ 2.4B
|
|
Net Cash Flow
|
$ 352.3M
|
$ 259.1M
|
$ -1157.2M
|
|
PE Ratio
|
30.72
|
|
|
| Splits |
|
May 13, 2002:
2:1
|
|
Jun 12, 2001:
2:1
|
|
May 04, 2000:
1:10
|
|
|
|
